Tsokos GC. Systemic lupus erythematosus. N Engl J Med 2011 ; 365 : 2110 - 21 .

Alves JD , Ames PR. Atherosclerosis, oxidative stress and auto-antibodies in systemic lupus erythematosus and primary antiphospholipid syndrome. Immunobiology 2003 ; 207 : 23 - 8 .

Morgan PE , Sturgess AD , Davies MJ. Increased levels of serum protein oxidation and correlation with disease activity in systemic lupus erythematosus. Arthritis Rheum 2005 ; 52 : 2069 - 79 .

Obinger C. Chemistry and biology of human peroxidases. Arch Biochem Biophys 2006 ; 445 : 197 - 8 .

Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukoc Biol 2005 ; 77 : 598 - 625 .

Hampton MB , Kettle AJ , Winterbourn CC. Inside the neutrophil phagosome: oxidants, myeloperoxidase, and bacterial killing. Blood 1998 ; 92 : 3007 - 17 .

Salonen I , Huttunen K , Hirvonen MR , et al. Serum myeloperoxidase is independent of the risk factors of atherosclerosis. Coron Artery Dis 2012 ; 23 : 251 - 8 .

Madhusudhana Rao A , Anand U , Anand CV. Myeloperoxidase in chronic kidney disease. Indian J Clin Biochem 2011 ; 26 : 28 - 31 .

Garrity-Park M , Loftus EV Jr , Sandborn WJ , et al. Myeloperoxidase immunohistochemistry as a measure of disease activity in ulcerative colitis: association with ulcerative colitis-colorectal cancer, tumor necrosis factor polymorphism and RUNX3 methylation. Inflamm Bowel Dis 2012 ; 18 : 275 - 83 .

Fernandes RM , da Silva NP , Sato EI . Increased myeloperoxidase plasma levels in rheumatoid arthritis. Rheumatol Int 2012 ; 32 : 1605 - 9 .

Telles RW , Ferreira GA, da Silva NP, et al. Increased plasma myeloperoxidase levels in systemic lupus erythematosus. Rheumatol Int 2010 ; 30 : 779 - 84 .

Hochberg MC . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1997 ; 40 : 1725 .

Bombardier C , Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients . Arthritis Rheum 1992 ; 35 : 630 -40.

Hansson GK . Inflammation, atherosclerosis, and coronary artery disease . N Engl J Med 2005 ; 352 : 1685 -95.

van der Veen BS , de Winther MP, Heeringa P. Myelo- peroxidase: molecular mechanisms of action and their relevance to human health and disease . Antioxid Redox Signal 2009 ; 11 : 2899 -937.

Ren Y , Tang J, Mok MY, et al. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus . Arthritis Rheum 2003 ; 48 : 2888 -97.

Pradhan VD , Badakere SS, Bichile LS, et al. Anti- neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies . J Assoc Physicians India 2004 ; 52 : 533 -7.